DNA-decoded Libraries of Reversible, Covalent Protein Ligands
Award amount
$225,000Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- DELUGE BIOTECHNOLOGIES INC
- Proposal award date
- 2019-09-01
- Contract end date
- 2020-08-31
- UEI
- M3BMLW3N5N36
- Solicitation number
- PA18-574
- Topic code
- 300
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- High-Throughput Screening for the Discovery of Protein-Binding Fragments
- Asymmetric synthesis of DNA-encoded libraries of natural product-like compounds.
- Synthesis and screening of DNA-encoded Libraries of Non-Peptidic Macrocycles
- I-Corps Supplement to parent grant DNA Encoded Macrocycles Libraries As A Source of Protein-Protein Interaction Inhibitors
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
- Combinatorial pipeline for discovery of anti-GPCR Nanobodies
- Development of a GBP-based glycosylation analysis system
- Extended-release injectable gel for multi-day treatment of postoperative pain
- eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening
Research funding history
5 SBIR/STTR records share this UEI (2018–2023). Reported award amounts total $2,471,294. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services